Search results for "Cholinesterase Inhibitor"

showing 10 items of 57 documents

Temperature–Time Relationship in Collembolan Response to Chemical Exposure

1999

Abstract Effects of temperature on chemical toxicity to a collembolan, Folsomia candida , in relation to time were studied in this experiment. Field soil was used as a test substrate. Collembolans were incubated at three different temperatures (+13, +16, and +19°C) and in two different dimethoate concentrations (1 and 3 mg/kg), clean soil serving as the control. Four destructive samplings were done at 2-week intervals. Dimethoate degradation was also analyzed. Dimethoate 1 mg/kg had a slight effect on both adult growth and reproduction, whereas 3 mg/kg was fatal to F. candida in the soil used. Toxic effects tended to last longer at low temperature than at high temperature, but the differenc…

InsecticidesTime FactorsHealth Toxicology and Mutagenesismedia_common.quotation_subjectmedicine.disease_causeIsotomidaechemistry.chemical_compoundAnimal sciencemedicineAnimalsSoil PollutantsEcotoxicologyDimethoateArthropodsmedia_commonbiologyChemistryEcologyTemperaturePublic Health Environmental and Occupational HealthEnvironmental factorSubstrate (chemistry)General MedicinePesticidebiology.organism_classificationPollutionSoil contaminationCold TemperatureBiodegradation EnvironmentalLarvaCholinesterase InhibitorsReproductionDimethoateEcotoxicology and Environmental Safety
researchProduct

Expression and function of the non-neuronal cholinergic system in endothelial cells

2003

Increasing evidence has shown the expression of the non-neuronal cholinergic system in endothelial cells. In the present experiments the expression of choline acetyltransferase (ChAT) was investigated in human endothelial cells by anti-ChAT immunohistochemistry and anti-ChAT immunofluorescence. Positive ChAT immunoreactivity was found in cultures of human umbilical endothelial cells (HUVEC) and a human angiosarcoma cell line (HAEND). In HUVEC and HAEND choline acetyltransferase activity and small amounts of acetylcholine were also detected. Positive ChAT-immunoreactivity was demonstrated in situ in endothelial cells of the human umbilical cord. In addition, in experiments with confocal lase…

LipopolysaccharidesNicotinePathologymedicine.medical_specialtyEndotheliumPhysostigmineeducationHuman skinBiologyImmunofluorescenceGeneral Biochemistry Genetics and Molecular BiologyCell LineCholine O-Acetyltransferasemental disordersTumor Cells CulturedmedicineHumansNicotinic AgonistsGeneral Pharmacology Toxicology and PharmaceuticsChromatography High Pressure LiquidMicroscopy Confocalmedicine.diagnostic_testCell adhesion moleculeAntibodies MonoclonalGeneral MedicineImmunohistochemistryCholine acetyltransferaseAcetylcholinehumanitiesCell biologymedicine.anatomical_structureNicotinic agonistnervous systemCell cultureCholinesterase InhibitorsEndothelium VascularCell Adhesion MoleculesAcetylcholineSignal Transductionmedicine.drugLife Sciences
researchProduct

Combination of intensive cognitive rehabilitation and donepezil therapy in Alzheimer's disease (AD).

2009

Acetylcholinesterase inhibitors (AchEIs) are extensively used in Alzheimer's disease (AD) while reality orientation therapy (ROT) is a cognitive rehabilitation indicated for mentally deteriorated patients. We aimed to evaluate the efficacy of the combination of donepezil with an intensive ROT with active participation of the caregiver. Patients with AD (n=100, mean age 78.4±4.3 years) initiated treatment with donepezil, 5mg/day; 62 of them underwent a 3-week, daily ROT and physical reactivation training with the caregiver (Group A); 38 participants received only donepezil therapy (Group B). All subjects were tested for cognitive and functional abilities at baseline, at the end of the traini…

MaleAgingmedicine.medical_specialtyHealth (social science)Diseasechemistry.chemical_compoundPiperidinesAlzheimer Diseasemental disordersmedicineDementiaHumansDonepezilCognitive rehabilitation therapyDonepezilAgedAged 80 and overPsychiatric Status Rating ScalesAnalysis of VarianceChi-Square DistributionCognitive Behavioral TherapyCognitionmedicine.diseaseAcetylcholinesteraseActive participationTreatment OutcomechemistryIndansPhysical therapyFemaleCholinesterase InhibitorsGeriatrics and GerontologyTraining programPsychologyGerontologymedicine.drugArchives of gerontology and geriatrics
researchProduct

Acetylcholine overflow from isolated perfused hearts of various species in the absence of cholinesterase inhibition

1977

1. The content of acetylcholine in the tissue and effluent of isolated hearts of various birds and mammals was determined in the absence of inhibition of cholinesterase. 2. Stimulation of both vagus nerves for 15 min at 20 Hz caused marked negative chronotropic effects in all species. Spontaneous or stimulation-induced overflow of acetylcholine into the effluents was not detected in mammals. In the avian heart, the order of spontaneous overflow was: duck = chicken > pigeon, whereas the order of evoked overflow was: chicken > pigeon > duck. The acetylcholine overflow from the cat heart was below the limit of estimation (3 pmol g−1 min−1). In the chicken heart, the evoked overflow per min (28…

MaleChronotropicmedicine.medical_specialtyPhysostigmineanimal structuresAcetylcholine synthesisPhysostigmineGuinea PigsStimulationIn Vitro TechniquesBiologyBirdsParasympathetic nervous systemSpecies SpecificityInternal medicinemedicineAnimalsColumbidaeCholinesteraseMammalsPharmacologyMyocardiumVagus NerveGeneral MedicineAcetylcholineElectric StimulationCholinesterase inhibitionDucksEndocrinologymedicine.anatomical_structurenervous systemCatscardiovascular systembiology.proteinFemaleCholinesterase InhibitorsRabbitsChickensAcetylcholinemedicine.drugNaunyn-Schmiedeberg's Archives of Pharmacology
researchProduct

Effect of controlled-release delivery on the pharmacokinetics of oxybutynin at different dosages: severity-dependent treatment of the overactive blad…

2004

OBJECTIVE To assess the pharmacokinetics of a controlled-release formulation of oxybutynin (OROS®-O, ALZA Corp., Mountain View, CA) at different dosages, compared with immediate-release oxybutynin (IR-O), and to determine the pharmacodynamic properties in the severity-dependent reduction of urge urinary incontinence (UUI). PATIENTS AND METHODS In all, 105 patients were enrolled in this multicentre, randomized, double-blind study. Individual dose titration was used to assess the minimum effective, maximum tolerated or maximum allowed dose of either OROS-O or IR-O. Blood samples were collected during maintenance therapy with frequent sampling to analyse for R-oxybutynin and R-desethyloxybutyn…

MaleDoseUrologyUrinary incontinenceDouble-Blind MethodPharmacokineticsMaintenance therapymedicineHumansDosingOxybutyninDose-Response Relationship Drugbusiness.industryMiddle Agedmedicine.diseaseUrinary IncontinenceOveractive bladderDelayed-Action PreparationsAnesthesiaPharmacodynamicsMandelic AcidsFemaleCholinesterase Inhibitorsmedicine.symptombusinessmedicine.drugBJU International
researchProduct

Therapeutic Drug Monitoring for Patients With Alzheimer Dementia to Improve Treatment With Donepezil

2015

BACKGROUND Aiming to verify that therapeutic drug monitoring has the potential to optimize treatment with acetylcholine esterase inhibitors of patients with Alzheimer dementia, this study investigated whether serum concentrations of donepezil are associated with clinical improvement. METHODS Clinical improvement was measured using the clinical global impression (CGI) scale, and donepezil concentrations were measured in serum by a high-performance liquid chromatographic method with spectrophotometric detection. RESULTS In total, 206 serum samples from 106 patients (49.5% female) were retrospectively available for analysis. Patients included were treated under everyday conditions. Their mean …

MaleDrugmedicine.medical_specialtymedia_common.quotation_subjectGastroenterologyPiperidinesAlzheimer DiseaseInternal medicinemental disordersmedicineHumansDonepezilPharmacology (medical)DonepezilAgedRetrospective Studiesmedia_commonPharmacologyDose-Response Relationship DrugReceiver operating characteristicmedicine.diagnostic_testbusiness.industryRetrospective cohort studyAlzheimer dementiaDose–response relationshipTreatment OutcomeTherapeutic drug monitoringIndansClinical Global ImpressionFemaleCholinesterase InhibitorsDrug Monitoringbusinessmedicine.drugTherapeutic Drug Monitoring
researchProduct

Effect of cholinergic stimulation in early Alzheimer's disease - functional imaging during a recognition memory task.

2011

Treatment of Alzheimer's disease (AD) with acetylcholinesterase inhibitors (AChEI) enhances cholinergic activity and alleviates clinical symptoms. In the present functional magnetic resonance imaging (fMRI) study, we investigated the effect of the AChEI rivastigmine on cognitive function and brain activation patterns during a face recognition memory task. Twenty patients with newly-diagnosed mild AD were administered a single oral dose of placebo, a single dose of rivastigmine (acute), and twice-daily treatment with rivastigmine for 4 weeks (chronic). After each treatment, the patients underwent a facial recognition task during fMRI. The prefrontal areas known to be involved in face recogni…

MalePhenylcarbamatesRivastigmineBrain mappingDouble-Blind MethodAlzheimer DiseaseMemorymedicineImage Processing Computer-AssistedHumansPrefrontal cortexCognitive reserveRecognition memoryAgedRivastigmineBrain Mappingmedicine.diagnostic_testWorking memoryCognitionMagnetic Resonance ImagingNeurologyPattern Recognition VisualFemaleNeurology (clinical)Cholinesterase InhibitorsFunctional magnetic resonance imagingPsychologyNeurosciencemedicine.drugCurrent Alzheimer research
researchProduct

Effects of 5-HT4 receptor stimulation on basal and electrically evoked release of acetylcholine from guinea-pig myenteric plexus

1992

The effects of 5-methoxytryptamine and 5-hydroxytryptamine (5-HT) on both basal and electrically evoked outflow of tritium were studied in guinea-pig myenteric plexus preparations preincubated with [3H]-choline. Basal outflow. 5-Methoxytryptamine caused a transient and calcium-dependent increase in basal outflow of [3H]acetylcholine that was abolished by tetrodotoxin. Ondansetron (1 μmol/1) did not affect the stimulatory response of 5-methoxytryptamine but ICS 205-930 (1 and 3 μmol/1) produced parallel rightward displacements of the concentration-response curve to 5-methoxytryptamine. The PKB value for ICS 205-930 was 6.6 suggesting an involvement of 5-HT4 receptors. 5-HT caused an increase…

MaleSerotoninmedicine.medical_specialtyGuinea PigsNeuromuscular JunctionMyenteric Plexus5-HT4 receptorStimulationIn Vitro TechniquesBiologyTritium5-HT3 receptorCholine5-Methoxytryptaminechemistry.chemical_compoundIleumInternal medicinemedicineAnimalsReceptorMyenteric plexusPharmacologyMuscle SmoothGeneral MedicineSmooth muscle contractionAcetylcholineElectric StimulationStimulation ChemicalEndocrinologychemistryReceptors SerotoninMetitepinebiology.proteinFemaleCholinesterase InhibitorsAcetylcholinemedicine.drugNaunyn-Schmiedeberg's Archives of Pharmacology
researchProduct

The effects of racemic bethanechol and its (R)- and (S)-enantiomers on pre- and postjunctional muscarine receptors in the guinea-pig ileum

1985

The effect of racemic bethanechol and its (R)- and (S)-enantiomers on smooth muscle contraction and outflow of [3H]-acetylcholine were studied in the guinea-pig myenteric plexus-longitudinal muscle preparation that had been preincubated with [3H]-choline. (S)-, racemic, and (R)-bethanechol caused concentration-dependent contractions of the longitudinal muscle. The potency ratio of the strong isomer (S) to the weak one (R) was 915. Racemic and (S)-bethanechol concentration-dependently inhibited the evoked outflow of [3H]-acetylcholine. Racemic bethanechol was more potent than (S)-bethanechol. (R)-bethanechol up to a concentration of 1 mM did no affect the evoked outflow of [3H]-acetylcholine…

MaleStereochemistryGuinea PigsMyenteric PlexusBethanecholchemistry.chemical_compoundBethanechol CompoundsIleumMuscarinic acetylcholine receptormedicineAnimalsPharmacologyMuscarineChemistryMuscle SmoothStereoisomerismGeneral MedicineSmooth muscle contractionBethanecholReceptors MuscarinicRacemic mixtureFemaleCholinesterase InhibitorsEnantiomermedicine.symptomAcetylcholineMuscle Contractionmedicine.drugMuscle contractionNaunyn-Schmiedeberg's Archives of Pharmacology
researchProduct

Acetylcholinesterase inhibitors and memantine in bipolar disorder: A systematic review and best evidence synthesis of the efficacy and safety for mul…

2016

Abstract Background Acetylcholinesterase inhibitors (AceI) and memantine might prove useful in bipolar disorder (BD) given their neuroprotective and pro-cognitive effects, as highlighted by several case reports. We aimed to systematically review the efficacy and safety of AceI and memantine across multiple outcome dimensions in BD. Methods Systematic PubMed and SCOPUS search until 04/17/2015 without language restrictions. Included were randomized controlled trials (RCTs), open label studies and case series of AceI or memantine in BD patients reporting quantitative data on depression, mania, psychotic symptoms, global functioning, or cognitive performance. We summarized results using a best-…

Malelaw.inventionpsychosis.0302 clinical medicinePiperidinesRandomized controlled triallawDonepezilDonepezilRandomized Controlled Trials as Topicbipolar disorderClinical Trials as TopicEvidence-Based MedicineDepressionMemantineMiddle AgedManiaPsychiatry and Mental healthClinical PsychologyTreatment Outcomeacetylcholinesterase inhibitorsdepressionIndansFemalemedicine.symptomPsychologyManiamedicine.drugAdultmedicine.medical_specialtyBipolar disorderPlaceboBipolar disorder Acetylcholinesterase inhibitors Memantine Depression Mania Psychosis03 medical and health sciencesmaniaMemantineInternal medicinemedicineGalantamineHumansBipolar disorderAcetylcholinesterase inhibitors; Bipolar disorder; Depression; Mania; Memantine; Psychosis.PsychiatryDepressive DisorderGalantaminePsychosismedicine.disease030227 psychiatryAcetylcholinesterase inhibitorsMoodPsychotic DisordersAcetylcholinesterase inhibitors; Bipolar disorder; Depression; Mania; Memantine; Psychosis; Psychiatry and Mental Health; Clinical PsychologyCase-Control StudiesmemantineCholinesterase InhibitorsExcitatory Amino Acid Antagonists030217 neurology & neurosurgeryJournal of Affective Disorders
researchProduct